SMARTLOAD GCB00 (REF GCB0000230)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · SMARTLOAD TECNIS 1PC CLEAR MONO 23.0D · Class 3
All models of SMARTLOAD (52)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 8
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 05050474620667), received between Jul 6, 2021 and Jun 16, 2026 — classified as 4 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Break” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
- Break2
- Device Contaminated During Manufacture or Shipping1
- Material Fragmentation1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
- Toxic Anterior Segment Syndrome (TASS)2
- Endophthalmitis1
- Eye Infections1
Recent adverse event reports
The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 16, 2026Material Fragmentation
IT WAS REPORTED THAT DURING IMPLANTATION OF THE PRELOADED INTRAOCULAR LENS (IOL), IT RELEASED DEBRIS INTO THE CAPSULAR BAG. NO IMPACT ON THE PATIENT WAS REPORTED. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25524406 ↗InjuryJun 9, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE SITE HAS IDENTIFIED A BACTERIAL INFECTION AFFECTING THEIR OPHTHALMOLOGY PATIENTS. AT THIS TIME, IT IS NOT KNOWN WHETHER THE INFECTION IS RELATED TO JOHNSON AND JOHNSON LENSES, BUT THE HOSPITAL HAS NOTIFIED ALL OPHTHALMOLOGY SUPPLIERS AS A PRECAUTION. THROUGH FOLLOW UP, WE LEARNED THAT A TOTAL OF FIVE PATIENTS WERE AFFECTED BY SUSPECTED ENDOPHTHALMITIS, SPECIFIC DATES BELOW. ALL FIVE PATIENTS WERE TREATED WITH INTRAVITREAL ANTIBIOTICS, ORAL AND TOPICAL ANTIBIOTICS, AND ONE PATIENT ALSO REQUIRED TOPICAL STEROIDS. AS WE CANNOT RULE OUT ANY PRODUCTS, ALL SUSPECT PRODUCTS ARE REPORTED WITH ALL INTERVENTIONS PROVIDED. AT PRESENT THERE ARE NO LONG-TERM EFFECTS ON THE PATIENT'S VISION AND NO FURTHER INTERVENTIONS HAVE BEEN REQUIRED. THROUGH FURTHER FOLLOW UP, WE LEARNED THAT THE SUSPECT PRODUCTS FOR THESE COMPLAINTS ARE GCB MODEL INTRAOCULAR LENS (IOL), LAMINAR FLOW PHACO TIPS, TUBING SETS, AND DK9000 AS THEY WERE USED ON EACH PATIENT. AS THE DK9000 IS A DEVICE THE CLINIC STERILIZES THEMSELVES, THIS IS LISTED AS A CONCOMITANT DEVICE AND NOT BEING REPORTED AGAINST. THERE WAS NO DIFFERENTIATION AS TO WHICH PATIENT HAD WHICH SPECIFIC DEVICE AND AS SUCH, ALL FILES WILL
Patient problems: Endophthalmitis
MAUDE report 25452007 ↗MalfunctionJan 12, 2026Break
IT WAS REPORTED THAT THE PRELOADED INTRAOCULAR LENS (IOL) WAS FOUND DAMAGED. ISSUE OBSERVED UPON OPENING OF THE PACKAGING. NO PATIENT CONTACT WAS REPORTED. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24032103 ↗InjuryJan 6, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT POSTOPERATIVE TOXIC ANTERIOR SEGMENT SYNDROME (TASS) INFECTIONS WERE OBSERVED IN DIFFERENT PATIENTS ASSOCIATED WITH SIX DIFFERENT PRODUCT SERIAL NUMBERS. PATIENTS EXPERIENCED INFECTION, SOUGHT MEDICAL ATTENTION, AND WERE PRESCRIBED MEDICATION. ALL PATIENTS WERE REPORTED AS FULLY RECOVERED ALTHOUGH THEIR DAILY ACTIVITIES WERE SIGNIFICANTLY AFFECTED DURING THE EVENT. NO FURTHER INFORMATION WAS PROVIDED. SEPARATE REPORTS ARE BEING SUBMITTED FOR EACH PATIENT/ LENS.
Patient problems: Toxic Anterior Segment Syndrome (TASS)
MAUDE report 23985541 ↗InjuryJan 6, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT POSTOPERATIVE TOXIC ANTERIOR SEGMENT SYNDROME (TASS) INFECTIONS WERE OBSERVED IN DIFFERENT PATIENTS ASSOCIATED WITH SIX DIFFERENT PRODUCT SERIAL NUMBERS. PATIENTS EXPERIENCED INFECTION, SOUGHT MEDICAL ATTENTION, AND WERE PRESCRIBED MEDICATION. ALL PATIENTS WERE REPORTED AS FULLY RECOVERED ALTHOUGH THEIR DAILY ACTIVITIES WERE SIGNIFICANTLY AFFECTED DURING THE EVENT. NO FURTHER INFORMATION WAS PROVIDED. SEPARATE REPORTS ARE BEING SUBMITTED FOR EACH PATIENT/ LENS.
Patient problems: Toxic Anterior Segment Syndrome (TASS)
MAUDE report 23985529 ↗InjuryJun 26, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE SURGEON PERFORMED EIGHT CATARACT SURGERIES ON THE SAME DAY BEFORE EASTER. AT THE WEEKLY CHECK-UP EVERYTHING LOOKED FINE, BUT AT THE MONTHLY CHECK-UP THERE WAS A CLOUDY LIGHT PATH IN 3 EYES. WHEN TREATED WITH SPERSADEX IT DISAPPEARED QUICKLY. THE SURGEON DOES NOT SUSPECT OUR PRODUCTS AND HAS CHANGED EVERYTHING THAT CAN BE CHANGED. THROUGH FOLLOW UPS IT WAS CONFIRMED THAT THE 3 EYES WERE FROM 3 DIFFERENT PATIENTS. THROUGH FURTHER FOLLOW UP, WE LEARNED THAT 7 PATIENTS ARE INVOLVED AND THERE ARE 3 DIFFERENT EVENT DATES. IT WAS CONFIRMED THAT THE CUSTOMER IS REPORTING INFECTION IN ALL 7 PATIENTS. HOWEVER, ON JUNE 13TH IT WAS LEARNED THAT THE SURGEON DOES NOT BELIEVE THIS INCIDENT IS RELATED TO THE IMPLANTED JOHNSON AND JOHNSON INTRAOCULAR LENSES (IOLS). THROUGH FOLLOW UP ON JUNE 16TH WE LEARNED IT WAS A MILD INFECTION, ALL PATIENTS RESPONDED FAST TO TOBRADEX EXCEPT ONE THAT TOOK A LITTLE MORE TIME. THERE IS NO MATERIAL AVAILABLE FOR INVESTIGATION AS ALL IOLS REMAIN IMPLANTED. NO FURTHER INFORMATION WAS PROVIDED. NOTE: 6 ADDITIONAL REPORTS WILL BE FILED FOR THE OTHER 6 PATIENTS. THIS IS REPORT 6 OF 7.
Patient problems: Eye Infections
MAUDE report 22342839 ↗MalfunctionDec 31, 2024Break; Break
IT WAS REPORTED THAT THE INTRAOCULAR LENS (IOL) WAS BROKEN. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21048638 ↗MalfunctionJul 6, 2021Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping
IT WAS REPORTED THAT THE LENS WAS PREPARED ACCORDING TO THE INSTRUCTIONS. HOWEVER, A SICKLE-SHAPED PLASTIC PART WAS OBSERVED IN THE PATIENT'S EYE DURING IMPLANTATION OF THE LENS IN THE EYE, AND WAS ABLE TO BE RINSED OUT. EVENT DATE WAS AT THE END OF MAY. THROUGH FOLLOW UP IT WAS LEARNED THAT THE LENS WAS IMPLANTED AND THERE WAS NO HARM TO THE PATIENT. THE PROBLEM WAS IDENTIFIED DURING AND AFTER IMPLANTATION. NO ADDITIONAL INFORMATION PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12125776 ↗
Other intraocular lens devices
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens146 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens145 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens144 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens139 reports
- TECNIS SIMPLICITY DIB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens1 recall81 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens129 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens127 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens126 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page